Evidence map›Paper›PMID 33066945›Full record

GuidelineJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association2020

Current Recommendations for the Management of Stroke Patients in the Middle East in the Era of COVID-19 Pandemic; Statement from the MENA SINO.

Amal M Al Hashmi, Atilla Ozcan Ozdemir, Ashfaq Shuaib, Hosam Al-Jehani, Ossama Yassin Mansour, Adel Alhazzani, Farid Aladhem, Mehdi Farhoudi, Seby John, Maher Saqqur

Open access · bronzeAbstract readPractice Guideline
In one paragraph

Guideline in Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 8 countries.

Amal M Al HashmiCentral Stroke Unit, Ministry of Health of Oman, Khoula Hospital, Muscat, Oman Sr Consultant Neurologist, Head Central Stroke Unit Oman.
Atilla Ozcan OzdemirDivision of Neurology, Neurocritical Care, Eskisehir Osmangazi University, Turkey.
Ashfaq ShuaibDivision of Neurology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Hosam Al-JehaniDepartment of Neurosurgery, Interventional Neuroradiology &Critical Care Medicine, King Fahad Hospital of the university, Imam Abdulrahman, AL Khobar Saudi Arabia.
Ossama Yassin MansourAlexandria Faculty of Medicine Department of Neurology.
Adel AlhazzaniNeurology Unit, Medicine Department, College of Medicine, King Saud University Riyadh, Saudi Arabia.
Farid AladhemSpecialty Hospital, Amman, Jordan.
Mehdi FarhoudiNeuroscience Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Seby JohnNeurology and Neurointerventional Surgery at Cleveland Clinic Abu Dhabi, UAE.
Maher SaqqurDivision of Neurology, Department of Medicine, University of Alberta, Edmonton, AB, Canada; Trillium Hospital, University of Toronto at Mississauga, Mississauga ON Canada. Electronic address: msaqqur@ualberta.ca.
University of Alberta · CAAlexandria University · EGCleveland Clinic · USEskişehir Osmangazi University · TRKhoula Hospital · OMKing Fahd Hospital of the University · SAKing Saud University · SASpecialty Hospital, Jordan · JOTabriz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 pandemic has led to a change in the way we manage acute medical illnesses. This pandemic had a negative impact on stroke care worldwide. The World Stroke Organization (WSO) has raised concerns due to the lack of available care and compromised acute stroke services globally. The numbers of thrombolysis and thrombectomy therapies are declining. As well as, the rates and door-to treatment times for thrombolysis and thrombectomy therapies are increasing. The stroke units are being reallocated to serve COVID-19 patients, and stroke teams are being redeployed to COVID-19 centers. Covid 19 confirmed cases and deaths are rising day by day. This pandemic clearly threatened and threatening all stroke care achievements regionally. Managing stroke patients during this pandemic is even more challenging at our region. The Middle East and North Africa Stroke and Interventional Neurotherapies Organization (MENA-SINO) is the main stroke organization regionally. MENA-SINO urges the need to developing new strategies and recommendations for stroke care during this pandemic. This will require multiple channels of interventions and create a protective code stroke with fast triaging path. Developing and expanding the tele-stroke programs are urgently required. There is an urgent need for enhancing collaboration and cooperation between stroke expertise regionally and internationally. Integrating such measures will inevitably lead to an improvement and upgrading of the services to a satisfactory level.

Indexed as

Africa, NorthernConsensusCoronavirus InfectionsCOVID-19Delivery of Health Care, IntegratedHumansMiddle EastPandemicsPatient SafetyPneumonia, ViralPractice Patterns, Physicians'Psychological DistanceQuarantineRisk AssessmentRisk FactorsStrokeAcute StrokeChallengesCOVID-19 PandemicMiddle East and North Africa Stroke and Interventional Neurotherapies Organization (MENA SINO)RecommendationsStroke CareStroke ServicesWorld Stroke Organization (WSO)

Identifiers

PMID33066945
PMCPMC7375312
OpenAlexW3043922942

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.